Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Splenectomy in advanced chronic lymphocytic leukemia.

A Ferrant, J L Michaux, G Sokal

    Cancer
    |November 1, 1986
    PubMed
    Summary

    Splenectomy can improve blood counts in chronic lymphocytic leukemia (CLL) patients with enlarged spleens, normalizing hematocrit and platelet levels. However, this surgery did not extend survival in the evaluated patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Practical Epidemiology.

    Acta clinica Belgica·2016
    Same author

    The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party.

    Annals of oncology : official journal of the European Society for Medical Oncology·2014
    Same author

    Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation.

    Oncogene·2014
    Same author

    Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents.

    Leukemia·2013
    Same author

    Recommendations in the event of a suspected transfusion-related acute lung injury (TRALI).

    Acta clinica Belgica·2012
    Same author

    Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy.

    Bone marrow transplantation·2011

    Area of Science:

    • Hematology
    • Oncology

    Background:

    • Chronic lymphocytic leukemia (CLL) can cause splenomegaly, leading to cytopenias.
    • Splenectomy is a potential treatment option for symptomatic splenomegaly in CLL.

    Purpose of the Study:

    • To evaluate the efficacy of splenectomy in managing splenomegaly and associated hematological abnormalities in CLL patients.
    • To assess the predictive value of erythropoiesis and splenic red cell volume for splenectomy response.
    • To determine the impact of splenectomy on patient survival.

    Main Methods:

    • Evaluation of 40 CLL patients with splenomegaly for splenectomy.
    • 20 patients underwent splenectomy.
    • Assessment of hematocrit, platelet count, ferrokinetics, and splenic red cell volume.
    • Survival analysis comparing splenectomized and non-splenectomized patients.

    Main Results:

    • Splenectomy normalized hematocrit in 18/20 patients and platelet counts in 19/20 patients.
    • Satisfactory residual erythropoiesis predicted a good response in 18/20 patients.
    • Splenic red cell volume predicted hematocrit increase.
    • Transfusion needs were abolished in 13/14 patients.
    • Clinical improvement was observed in most patients, but survival was not improved.

    Conclusions:

    • Splenectomy is effective in improving hematological parameters in CLL patients with splenomegaly.
    • Erythropoiesis and splenic red cell volume can predict response to splenectomy.
    • Despite hematological benefits and clinical improvement, splenectomy does not improve overall survival in CLL.

    Related Experiment Videos